AC Immune (ACIU) Total Liabilities (2014 - 2025)

AC Immune (ACIU) has 12 years of Total Liabilities data on file, last reported at $136.8 million in Q4 2025.

• Quarterly Total Liabilities rose 1.04% year-over-year to $136.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $136.8 million (up 1.04% YoY) and the FY2025 annual result came in at $131.9 million, down 2.6% from the prior year.
• Total Liabilities held at $136.8 million in Q4 2025 per ACIU's latest filing, from $136.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $139.5 million in Q2 2025 and bottomed at $22721.8 in Q1 2021.
• The 5-year median for Total Liabilities is $24.1 million (2022), against an average of $57.3 million.
• The widest annual swing landed in 2021, when Total Liabilities tumbled 99.9%; it then surged 101824.74% in 2022.
• Tracing ACIU's Total Liabilities over 5 years: stood at $32.0 million in 2021, then slumped by 44.95% to $17.6 million in 2022, then surged by 42.08% to $25.0 million in 2023, then soared by 441.85% to $135.4 million in 2024, then gained by 1.04% to $136.8 million in 2025.
• Per Business Quant, the three latest ACIU Total Liabilities figures stand at $136.8 million (Q4 2025), $136.5 million (Q3 2025), and $139.5 million (Q2 2025).

Peer Comparison